4 completed. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 4 |
Follow Remifentanil: new trials by email Literature Review of Remifentanil trials Research Report on Remifentanil
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Optimal Dosage of Remifentanil for Vertebroplasty Initial remifentanil effect-site concentration - Remifentanil, Analgesia | Phase 4 | Completed | Tri-Service General Hospital (TSGH) | 80 | 2023-05-20 | 2025-01-08 |
| Comparison of the Effects of Remifentanil and Dexmedetomidine Administered Under General Anesthesia in Rhinoplasty Remifentanil 2 MG, dexmedetomidine - Rhinoplasty, Dexmedetomidine | Phase 4 | Completed | Baskent University | 50 | 2022-03-01 | 2022-10-10 |
| Comparison of Sufentanil, Fentanyl and Remifentanil in Combination With Midazolam During Bronchoscopy Under Conscious Sedation Sufentanil, Fentanyl, Remifentanil - Sufentanil, Remifentanil | Phase 4 | Completed | Guangzhou Institute of Respiratory Disease | 60 | 2019-01-15 | 2019-04-03 |
| Remifentanil vs Fentanyl During Cardiac Surgery and Chronic Thoracic Pain Fentanyl, Remifentanil - Chronic Pain, Sternotomy | Phase 4 | Completed | St. Antonius Hospital | 126 | 2014-02-01 | 2016-10-18 |
Agnosia (1) · Chronic Pain (1) · Pain (1)
Neurologic Manifestations (3) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Nervous System Diseases (1) · Neurobehavioral Manifestations (1) · Pain (1) · Perceptual Disorders (1)
Remifentanil (3) · Fentanyl (2) · Dexmedetomidine (1) · Midazolam (1) · Sufentanil (1)
Baskent University (1) · Guangzhou Institute of Respiratory Disease (1) · St. Antonius Hospital (1) · Tri-Service General Hospital (TSGH) (1)
China (1) · Netherlands (1) · Taiwan (1) · Turkey (Türkiye) (1)
PMID 23839319, PMID 25429720, PMID 28741894, PMID 30211725, PMID 34397727, PMID 36086764